Brief: Rovi's Subsidiary Buys Injectable Drug Product Manufacturing Site In Phoenix, Arizona
29/09/2025 17:06
Sept 29 (Reuters) - Laboratorios Farmaceuticos ROVI SA ROVI.MC: SUBSIDIARY SIGNS AGREEMENT TO BUY BMS PLANT IN ARIZONA ACQUISITION CLOSING EXPECTED IN FIRST HALF OF 2026 AGREEMENT INCLUDES $50 MILLION ANNUAL PAYMENT OVER INITIAL TERM OF FIVE YEARS Source text: ID:nCNM7lFSB2, nCNM8z4cfN Further company coverage: ROVI.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))